A study in Type 2 Diabetes Mellitus patients receiving blinded study drug to test a new study medication

Update Il y a 4 ans
Reference: EUCTR2013-004275-12

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To compare LY2409021 20 mg to placebo (PBO) on the change in hepatic fat fraction (HFF) from baseline (BL) to 6 months as measured by MRI in subjects with T2DM who are taking metformin (MET) and sulfonylurea (SU).


Inclusion criteria

  • Type 2 diabetes mellitus

Links